High expression of FOXP3, CD14, and ARG1 mRNA in the primary tumors of high-risk NB patients was predictive of better survival, suggesting that the immune status of the tumor may influence the natural history of this pediatric cancer. Here, CD14 is linked to neuroblastoma.